HomeMedical SpecialtiesCardiologyCardiac and cancer teams collaborate to offer innovative approach to treat the...

Cardiac and cancer teams collaborate to offer innovative approach to treat the electrical inner workings of the heart

Published on

By Kathryn Perrier

For patients with heart-rhythm issues called arrhythmias, they can experience palpitations, shortness of breath and fatigue. These patients are usually treated with a procedure called an ablation. However, for some frail, elderly patients who have other conditions, ablation is not a safe option.

Southlake Regional Health Centre’s (Southlake) cardiac and cancer teams have been working closely for the past two years with a team from Washington University in the United States that developed a new less-invasive approach to treating these patients.

The goal of this research was to try a new way to perform the procedure for those who have not been able to tolerate medical therapy and were too unstable to be treated with an ablation. Southlake’s first procedure, referred to as Stereotactic Body Radiation Therapy (SBRT) was performed on October 22, 2020.

This innovative approach involves a radiation treatment machine called a linear accelerator, which is typically used for treating cancer tumours. Now this machine is being used to burn away the part of the heart responsible for the patient’s life-threating arrhythmia. SBRT is non-invasive and only involves a 30-minute radiation treatment. The patient does not require anesthetic or invasive catheters to the heart.

The Cardioinsight vest.

Here is how it works: the patient comes in and is fitted with a Cardioinsight  vest, which is a vest outfitted with electrodes. They receive a CT scan with the vest on so the cardiac team can map out the patient’s arrhythmia.  This map is then combined with the diagnostic images of the area where the arrhythmia is occurring to identify the specific part of the heart needs to be targeted by the radiation treatment.

Dr. Khaykin says the benefits for patients to have this new option are a tremendous win for our team in providing leading-edge care. “We are thrilled to see that this option is available and it has been an honour to work together with our radiation oncology team and our U.S. colleagues to provide effective, safe options for our sickest patients,” says  Dr. Khaykin.

“This has been an amazing experience to use both cardiac and cancer team’s expertise and to come up with a less-invasive way to help patients with arrhythmias. My team is very proud to be part of this research and to provide this level of care alongside our cardiac team partners,” says Dr. Taremi.

Southlake is one of the few hospitals in Canada, and globally, to treat a patient with SBRT. This treatment required collaboration between nurses, heart rhythm and radiation therapists, radiation physicists, radiation oncologists, anesthesiologists, and electrophysiologists to plan and deliver treatment. The team is planning to perform the procedure for three more patients by the end of the year.

Kathryn Perrier is the manager, corporate communications at Southlake Regional Health Centre.

Latest articles

An ER doctor’s experience with long COVID – “My symptoms seemed endless”

On April 2022, another COVID wave was sweeping Toronto. It was the sixth since...

Tackling the issue of unused medication waste

When patients and programs don’t use all the medication that is prescribed, it is...

Obesity a risk factor for stillbirth, especially at term

Obesity is a risk factor for stillbirth, and the risk increases as pregnancy advances...

Prolonged cough? In most cases, patience is the treatment

Coughing after a respiratory infection is common and, in most cases, will resolve with...

More like this

Prolonged cough? In most cases, patience is the treatment

Coughing after a respiratory infection is common and, in most cases, will resolve with...

A New Era in Heart Failure Management: The Promise of Digital Therapeutics

Heart failure is one of the fastest growing cardiovascular conditions in the world that...

Funding to take LHSC developed technology global

On average it takes five to seven years to diagnose a rare disease. But,...

Milk and Colorectal Cancer: what does the research say?

Colorectal cancer is the fourth most common cancer in Canada and is more common...

Surgical guidance with AI

Researchers at UHN’s Toronto General Hospital Research Institute (TGHRI) have utilized artificial intelligence (AI)...

Report outlines public health response to COVID-19 outbreaks at mink farms

A report co-authored by Fraser Health Medical Health Officer Dr. Emily Newhouse and published...